Viewing Study NCT04272151


Ignite Creation Date: 2025-12-24 @ 11:56 PM
Ignite Modification Date: 2026-01-01 @ 11:47 PM
Study NCT ID: NCT04272151
Status: UNKNOWN
Last Update Posted: 2023-04-18
First Post: 2020-02-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of BCMA-Targeted CAR-T Therapy for Relapsed/Refractory Multiple Myeloma
Sponsor: Chongqing Precision Biotech Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module